| human | Q5 |
| P106 | occupation | researcher | Q1650915 |
| Q36245367 | Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study |
| Q43658789 | Alcohol drinking and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study |
| Q37096164 | Anthropometry and the Risk of Lung Cancer in EPIC |
| Q36600605 | Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk |
| Q46897498 | Common genetic variation in GATA-binding protein 3 and differential susceptibility to breast cancer by estrogen receptor alpha tumor status |
| Q44577591 | Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer |
| Q37713640 | Correlates of circulating ovarian cancer early detection markers and their contribution to discrimination of early detection models: results from the EPIC cohort |
| Q57054343 | Dietary Carbohydrates, Glycemic Index, Glycemic Load, and Endometrial Cancer Risk within the European Prospective Investigation into Cancer and Nutrition Cohort |
| Q57026291 | Dietary fat intake and risk of epithelial ovarian cancer in the European Prospective Investigation into Cancer and Nutrition |
| Q43518068 | Height, age at menarche and risk of hormone receptor-positive and -negative breast cancer: a cohort study |
| Q53082610 | Insulin-like growth factor I and risk of breast cancer by age and hormone receptor status-A prospective study within the EPIC cohort. |
| Q60472154 | Lifetime and baseline alcohol intakes and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition study |
| Q45399201 | Macronutrient intake and risk of urothelial cell carcinoma in the European prospective investigation into cancer and nutrition |
| Q57026715 | Menstrual and reproductive factors in women, genetic variation inCYP17A1, and pancreatic cancer risk in the European prospective investigation into cancer and nutrition (EPIC) cohort |
| Q46968610 | Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). |
| Q40143922 | Mutations and polymorphisms of the p21B transcript in breast cancer |
| Q35752042 | Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density Measures |
| Q33894035 | Plasma folate, related genetic variants, and colorectal cancer risk in EPIC. |
| Q38345889 | Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: Results from the EPIC cohort |
| Q43816644 | Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies |
| Q51779053 | The novel p21 polymorphism p21G251A is associated with locally advanced breast cancer. |
| Q57054188 | Variation in genes coding for AMP-activated protein kinase (AMPK) and breast cancer risk in the European Prospective Investigation on Cancer (EPIC) |
Search more.